This week I talk about the medication shortages across the United States. Drugs used to treat ADHD, chronic pain, and other conditions have been in short supply lately for reasons unexplained. Different groups have blamed the shortage on one anther: the manufacturers blame the DEA, while the DEA blames manufacturers. But as usual, the problem comes down to a design issue.
For more about Assent's issues with the DEA, check out the Reason article, "DEA Shuts Down Factory even as Adderall Shortage Persists."
This week I talk about the medication shortages across the United States. Drugs used to treat ADHD, chronic pain, and other conditions have been in short supply lately for reasons unexplained. Different groups have blamed the shortage on one anther: the manufacturers blame the DEA, while the DEA blames manufacturers. But as usual, the problem comes down to a design issue.
For more about Assent's issues with the DEA, check out the Reason article, "DEA Shuts Down Factory even as Adderall Shortage Persists."